Sort
35,931 grants matching “parkinsons”
Neuronal Autophagy: a Cell-Autonomous Protection Mechanism
$363,366Zhenyu Yue · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · NS
Using BAC-transgenic and Proteomic Approach to Study LRRK2 Biology and Pathology
$363,366Zhenyu Yue · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · NS
Using BAC-transgenic and Proteomic Approach to Study LRRK2 Biology and Pathology
$363,366Zhenyu Yue · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · NS
Neuronal Autophagy: a Cell-Autonomous Protection Mechanism
$363,366Zhenyu Yue · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · NS
Molecular Screens for Deubiquitinase Function
$363,348Progenra, Inc. · R43 · FY2005 · DK
Lewy body neuropathologies and SNCA gene: variants expression and splicing
$363,340Ornit Chiba-Falek · Duke University · R01 · FY2017 · NS
Lewy body neuropathologies and SNCA gene: variants expression and splicing
$363,340Ornit Chiba-Falek · Duke University · R01 · FY2015 · NS
Lewy body neuropathologies and SNCA gene: variants expression and splicing
$363,340Ornit Chiba-Falek · Duke University · R01 · FY2016 · NS
Recessive parkinsonism and mitochondrial function
$363,338Mark Cookson · National Institute On Aging · ZIA · FY2010 · AG
Role of the Male-Specific Factor Sry in Brain Function
$363,308Eric J Vilain · University Of California Los Angeles · R01 · FY2010 · MH
Eye Movement Control: Cortical & Subcortical Mechanisms
$363,255Paul W Glimcher · New York University · R01 · FY2012 · EY
Prospective study of biomarkers and risk factors for ALS incidence and progressio
$363,251Alberto Ascherio · Harvard School Of Public Health · R01 · FY2013 · NS
Cholinergic modulation of olfactory bulb glomerular sensitivity
$363,245Max L Fletcher · University Of Tennessee Health Sci Ctr · R01 · FY2017 · DC
Prevention of Inherited Retinal Diseases by Therapeutic Rare Earth Nanoparticles
$363,220James Francis McGinnis · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2010 · EY
COMT inhibition as a potential therapeutic target among individuals with comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder
$363,188Joseph P Schacht · University Of Colorado Denver · R01 · FY2021 · AA
COMT inhibition as a potential therapeutic target among individuals with comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder
$363,188Joseph P Schacht · University Of Colorado Denver · R01 · FY2020 · AA
COMT inhibition as a potential therapeutic target among individuals with comorbid Alcohol Use Disorder and Attention-Deficit/Hyperactivity Disorder
$363,188Joseph P Schacht · University Of Colorado Denver · R01 · FY2022 · AA
GRAFTING GENETICALLY MODIFIED CELLS TO THE BRAIN
$363,165Salk Institute For Biological Studies · R37 · FY2000 · AG
Regulation of the oligodendroglial accumulation of alpha-synuclein in Multiple System Atrophy
$363,165Paula Alejandra Desplats · University Of California, San Diego · R01 · FY2016 · NS
Novel Neuroprotective Treatment for Parkinson's Disease
$363,146Aloke K Dutta · Wayne State University · R01 · FY2011 · NS
REST-Activated Program of Gene Expression in Ischemia
$363,125R. Suzanne Zukin · Albert Einstein College Of Medicine · R01 · FY2010 · NS
Targeted Neuroprotection for HIV-1 Associated Dementia
$363,118University Of Rochester · P01 · FY2005 · MH
ADMINISTRATIVE CORE
$363,113Jeffrey L. Cummings · University Of California Los Angeles · P50 · FY2013 · AG
On-chip studies of neuron cells under magnetic field stimulation
$363,113Long Que · Iowa State University · · FY2016 · ENG
PLASTICITY IN THE AGING OLFACTORY SYSTEM
$363,023Winifred Masterson Burke Med Res Inst · R01 · FY2005 · AG